ورش عمل

Showing 76–85 of 85 results

  • CTD Quality Module 3 For health and herbal products Chemistry Manufacturing and Control (CMC) Of product quality requirements 2 March, 2021 Riyadh

    The Pharmaceutical Development Module should describe the knowledge that establishes that the type of dosage form selected, and the formulation proposed are suitable for the intended use. This module should include sufficient information in each part to provide an understanding of the development of the drug product and its manufacturing process. CMC is an integral part of drug development, a regulatory submission and the on-going marketing and life cycle management of a medicinal product. As drug development of the dosage form moves from concept to commercialization, the breadth and depth of CMC documentation required in submissions increase in parallel.

    1,500.00 SAR
    Details
    Book ticket

  • Health and Herbal Products Development Process and Regulatory Approval 1 March, 2021 Riyadh

    Understanding drug regulatory affairs in the GCC region is  very important for persons working in pharmaceutical  sector in the region. This course is specifically designed for  persons working in the regulatory affairs departments or  related fields, who need knowledge of the SFDA and GCC  regulatory processes. This training will also enhance  understanding and be beneficial to persons who work in  clinical research, data management, basic research,  project management and marketing, etc.

    1,000.00 SAR
    Details
    Book ticket

  • Pharmaceuticals Pricing SFDA System Explained 3 March, 2021 Riyadh

    The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.

    2,000.00 SAR
    Details
    Book ticket

  • Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 1 June, 2021 Riyadh

    The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.

    2,000.00 SAR
    Details
    Book ticket

  • Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 14 March, 2022 Riyadh

    The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.

    2,000.00 SAR
    Details
    Book ticket

  • Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 14 September, 2021 Riyadh

    The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.

    2,000.00 SAR
    Details
    Book ticket

  • Pharmaceuticals Pricing, Reimbursement and Market Access. SFDA System Explained 22 June, 2022 Riyadh

    The rise in costs of pharmaceutical products in general affects all sectors of the health care industry, including private insurers and patients. This workshop shall give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR. In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.

    2,000.00 SAR
    Details
    Book ticket

  • Post Approval Activities and Compliance: Variations Guideline 15 March, 2021 Riyadh

    This course will provide an overview and analysis of the various regulatory activities that take place post-approval: In particular, the current regulatory climate will be discussed in depth and numerous examples will be provided to illustrate effective filing of notification techniques. Common issues which have caused difficulties for pharmaceutical firms will also be discussed.  The training will discuss in detail the GCC guideline for variations management and post approval commitment.

    1,500.00 SAR
    Details
    Book ticket
  • Sale!

    Preparing VNeeS Submission 11 April, 2021 Riyadh

    This course will offer insight into the compilation of the VNees, share experience and best practices gained during VNees  submissions to SFDA.

    • Overview of VNees readiness at the agencies
    • Impact of the VNees on regulatory processes and procedures
    • VNees compilation and life cycle management
    • VNees Validation
    • Document granularity and readiness
    • Technical issues
    • Specifications and standards

    Original price was: 2,000.00 SAR.Current price is: 1,500.00 SAR.
    Details
    Book ticket

  • Preparing VNeeS Submission 31 March, 2021 Riyadh

    This course will offer insight into the compilation of the VNees, share experience and best practices gained during VNees  submissions to SFDA.

    • Overview of VNees readiness at the agencies
    • Impact of the VNees on regulatory processes and procedures
    • VNees compilation and life cycle management
    • VNees Validation
    • Document granularity and readiness
    • Technical issues
    • Specifications and standards

    2,000.00 SAR
    Details
    Book ticket
Page 6 of 6
« Previous Page